MedPath

Self-monitoring and personalized feedback as a tool to boost depression treatment

Conditions
Depression, depressie
Registration Number
NL-OMON29201
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

In order to be eligible to participate in the study, a subject must meet the following criteria:

-Depression treatment is indicated by the practitioner

Exclusion Criteria

Exclusion criteria (based on appraisals by the practitioner) are:

-Crisis intervention warranted (i.e. in the case of acute suicidality)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure to determine effectiveness of the intervention will be the change in depression symptom severity as measured by the self-report Inventory of Depressive Symptomatology (IDS-SR, Rush et al., 1996) across 6 time points: baseline, after 4 weeks of ESM and at 4 follow-ups at 4, 8, 12, and 24 weeks (post-ESM). Subjects will be followed prospectively to compare the effectiveness of the intervention modules mutually and to the control group, before and during TAU.
Secondary Outcome Measures
NameTimeMethod
From a patient perspective, functional outcomes are at least as relevant as clinical outcomes. Therefore, we will also assess change in psychosocial functioning by means of the Outcome Questionnaire (OQ-45, Lambert et al., 1996) and the extent to which individuals regain self-esteem and take control over their own lives by means of the Dutch Empowerment questionnaire (NEL; Boevink, Kroon, & Giesen, 2010). <br /><br /><br><br>Cost-effectiveness will be determined by the means of the quality of life measure EQ-5D (Prieto et al., 2013) and the TiC-P questionnaire on medical costs and productivity losses (Bouwmans et al. 2013) adjusted for a psychiatric population. <br><br><br>
© Copyright 2025. All Rights Reserved by MedPath